These survivors are among the few who have received Bedaquiline & Delamanid at @MSF's clinic in #Mumbai. Despite the benefits of drugs, they remain out of reach for most DR-TB patients. This #WorldTBDay , we appeal to make the new #tuberculosis drugs accessible for those who need
02:17 - 24 Mar 2019